Approval was based on the pivotal Phase 3 CodeBreaK 300 study.

Designed to increase throughput, decrease COGS, and reduce batch failures.

Offers first-opening indication, oxygen and light protection, and can include an RFID chip for drug traceability and inventory management.

Under the agreement, AGC Biologics will manufacture the lentiviral vector used to produce lete-cel, an engineered T-cell ...

Ravensburg, January 14, 2025: Vetter, a globally operating Contract Development and Manufacturing Organization (CDMO), has ...

Caris Life Sciences, a provider of molecular profiling and artificial intelligence (AI)-driven solutions for cancer treatment ...

The treatment will be stockpiled and available for rapid deployment as part of the SNS CHEMPACK program.

Lyndra Therapeutics, a clinical-stage biopharmaceutical company, has entered a strategic collaboration with Thermo Fisher ...

CGMP cytokines now available for Charles River’s Cell Therapy Flex Platform.

IDT Biologika, a global contract development and manufacturing organization (CDMO), has appointed Federico Pollano as Chief ...

Emmes Group, a specialty tech and AI-enabled global contract research organization (CRO), has appointed Germaine Gross as ...

Piramal Pharma Limited has achieved an environmental milestone at its API and intermediates manufacturing facility in Digwal, ...